ReviewInternational journal of molecular sciences2023

SGLT2 Inhibitors: A New Therapeutical Strategy to Improve Clinical Outcomes in Patients with Chronic Kidney Diseases.

Assunta Di Costanzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.